UBS Group’s SEQUENOM INC NEW SQNM Stock Holding History

UBS Group’s Portfolio SQNM Stock Details SQNM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-14,925	Closed	-$14K	–	8267
2016 Q2	$14K	Buy	14,925 +200	+1%	+$238	﹤0.01%	6599
2016 Q1	$21K	Sell	14,725 -11,126	-43%	-$16.6K	﹤0.01%	6184
2015 Q4	$42K	Buy	25,851 +7,323	+40%	+$12.5K	﹤0.01%	5988
2015 Q3	$32K	Sell	18,528 -3,800	-17%	-$9.3K	﹤0.01%	6241
2015 Q2	$68K	Hold	22,328	–	–	﹤0.01%	5729
2015 Q1	$88K	Sell	22,328 -8,888	-28%	-$32.6K	﹤0.01%	5530
2014 Q4	$116K	Buy	+31,216	New	+$101K	﹤0.01%	5556

UBS Group's SQNM Position: Q3 2016 in Review

UBS Group sold out of SEQUENOM INC NEW (SQNM) in Q3 2016, closing a stake of 14,925 shares — an estimated $14K sold.

UBS Group first reported a position in SQNM in Q4 2014 and held it in 7 quarters. The position peaked at $116K in Q4 2014. 0 funds tracked by Wall St. Rank hold SQNM as of Q3 2016.

UBS Group reported no remaining SEQUENOM INC NEW position as of Q3 2016 after selling out during the quarter.
UBS Group sold 14,925 SEQUENOM INC NEW shares in Q3 2016, an estimated $14K.
UBS Group first reported a position in SEQUENOM INC NEW in Q4 2014 and held it in 7 quarters.
UBS Group's SEQUENOM INC NEW position peaked at $116K in Q4 2014.
0 funds tracked by Wall St. Rank held SEQUENOM INC NEW as of Q3 2016.

Based on UBS Group's 13F filing for Q3 2016, filed 14 Nov 2016.